Back to Publications
November, 2023
BlueClinical is a founding member of the new pan-European CRO Astrum.
BlueClinical is a founding member of the new pan-European CRO Astrum.
For more information about the new range of available services, visit the new Company's website at www.astrumcro.com.
BlueClinical is a founding member of the new pan-European CRO Astrum, the result of a merger with three other European Companies with complementary skills (Bioclever, from Spain; Popsicube, from France; and Pharmalog, from Germany), and with investment from Henko Partners.
Other Publication
BlueClinical @ Swiss Biotech Day 2023
BlueClinical will be present at Swiss Biotech Day 2023. It will be held on April 24-25, 2023 in Basel, Switzerland. Contact us to schedule a meeting at: bd@blueclinical.pt
BlueClinical is a proud gold sponsor of the 2nd Bioequivalence Workshop
We are happy to announce that BlueClinical is a proud gold sponsor of the 2nd Bioequivalence Workshop by Medicines for Europe, which is scheduled to take place on 26 April 2023 in Brussels, Belgium.
